Navigation Links
New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes

effects. Telmisartan has a longer duration of action than all other members of the ARB class; it takes approximately 24 hours for half the dose of telmisartan to be eliminated from the body compared to five to 15 hours for other ARBs.(7,8) Telmisartan is 99.5% bound to serum protein and is excreted almost entirely via non-renal pathways. Clinical trials have shown that telmisartan provides powerful and consistent blood pressure reduction over a full 24 hour period.(7-10)

About Telmisartan (Micardis(R)/Kinzal(R)/Pritor(R))

Telmisartan is a member of the angiotensin II receptor blocker (ARB) class and is being investigated in the most ambitious and far-reaching research programme ever conducted with an ARB. In the clinical trial programmes PROTECTION, ONTARGET and PRoFESS, over 58,000 patients have been enrolled to investigate the cardiovascular protective effects of Telmisartan.

Telmisartan was discovered and developed by Boehringer Ingelheim. Under the trademarks Micardis(R) and MicardisPlus(R) (combination with HCTZ) the company markets Telmisartan in 84 countries around the world, including the USA, Japan and European countries. Telmisartan is marketed in cooperation with Astellas Pharma Inc. in Japan, Bayer HealthCare in Europe and GlaxoSmithKline in selected markets. Bayer HealthCare promotes Telmisartan under the brand names Kinzalmono(R), Kinzalkomb(R) (combination with HCTZ), and Pritor(R) and PritorPlus(R) in markets across Europe. Pritor(R) and PritorPlus(R) is also marketed by GlaxoSmithKline in selected markets.

Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and almost 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to resea
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:4/27/2015)... , April 27, 2015  As the Innovation Insight ... Philadelphia , InCrowd, provider of on-demand answers ... of life science insights experts in charting a new ... and innovation in research. Presented jointly by ... by Communispace Health, IIeX Health features TED-style presentations and ...
(Date:4/27/2015)... April 27, 2015 - The First ... by the State Intellectual Property Office of China ... Pooling Technology  - A New Treatment Which Offers ... - About 20% of Elderly Urban Chinese Suffer ... is Substantially Higher Than in Men. CLI is a Progressive ...
(Date:4/26/2015)... , April 26, 2015 Cancer experts ... VAR ) supported project in the area of distributed ... data" for the benefit of patients. Speakers at a ... Society for Therapeutic Radiation Oncology) forum in Barcelona ... treatment and applying that knowledge to help benefit the ...
Breaking Medicine Technology:InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 2InCrowd Helps IIeX Health 2015 Chart New Paths for Turning Physician Insights Into Innovation 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3
... SILVER SPRING, Md., Oct. 28 The U.S. ... indication for Sprycel (dasatinib) for the treatment of ... diagnosed. The cancer, called Philadelphia chromosome positive chronic ... slowly progressing blood and bone marrow disease linked ...
... Pharmaceuticals Inc. (Nasdaq: CPIX ) announced today ... the market closes on Thursday, November 11, 2010.  A conference ... November 11, 2010 at 5:00 p.m. Eastern Time to discuss ... dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). ...
Cached Medicine Technology:FDA Approves Additional Medical Indication for Sprycel 2FDA Approves Additional Medical Indication for Sprycel 3Cumberland Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 11, 2010 2
(Date:4/27/2015)... April 27, 2015 Douglas Fitzpatrick ... his clients feel secure, but also helps secure homes for ... p.m., Douglas will be manning a booth at the 2015 ... Building, 717 E. 17th Ave., Columbus, Ohio. , “I ... that will feature hundreds of adoptable pets from more than ...
(Date:4/27/2015)... April 27, 2015 On May 15, ... a social media campaign to raise awareness of the ... Mamas; and Sri Somesvara Temple. Ironically, when many of ... North Carolina, they thought they were leaving the social ... least six months of meditation, service to a higher ...
(Date:4/27/2015)... Attorney Dan Newlin, of the Law Offices of Dan ... that commitment to a whole new level with the introduction ... for existing and potential clients to contact the law firm. ... value to the firm’s services, #Dan covers Central Florida, South ... offices. , “I knew the pound sign (#) could be ...
(Date:4/27/2015)... Miami, FL (PRWEB) April 27, 2015 ... policies from arresting nonviolent drug offenders to providing drug ... by Nepr on April 8th. Several states, ... cut state costs revolving incarceration. Texas has formed community ... populace. According to The Council of State Governments ...
(Date:4/27/2015)... Climate change predictions are largely based on ... of variables used and the availability of large amounts ... Gerald Pollack, PhD, and Climatologist L.DeWayne Cecil, PhD, appearing ... show, noted three potential weaknesses that could impact the ... individuals dispute that Earth’s climate is changing. Nor do ...
Breaking Medicine News(10 mins):Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Mount Soma Monks Do Social Media 2Health News:Dan Newlin Hashtags It With #Dan 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 2Health News:Global warming: Computer weather models flawed report Climatologist, Water Researcher on Sharon Kleyne Hour™ radio show 3
... breast cancer on screening mammography report no family history, a new ... Care, LLC in Rochester, NY of all breast cancers diagnosed between ... were found in women, aged 40-49 with no family history of ... a prior personal history of breast cancer or abnormal cells at ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... a heart valve disease known as aortic stenosis, a ... effective, French researchers say. Transcatheter aortic-valve implantation is ... valve than traditional open-heart surgery. The procedure involves passing ...
... HealthDay Reporter , WEDNESDAY, May 2 (HealthDay News) -- ... (bird) flu virus can morph -- with the possibility that it ... -- may help nations prepare for the impending threat. That,s ... study in the May 2 online issue of Nature , ...
... mTOR stops the growth of primary liver cancer and destroys ... Group of Metabolism and Cancer at Bellvitge Biomedical Research Institute ... edition of the journal Science Translational Medicine . ... common cancer and, due to its aggressiveness, is the third ...
... 2012. Kessler Foundation will be represented by four scientists at ... to be held at the Congress Center in Bordeaux, France ... Foundation,s VP of Research and Training will attend with research ... PhD. Kessler Foundation is known for rehabilitation research ...
... 2 (HealthDay News) -- Chemistry in three areas of ... small study says. Along with providing new information ... important in finding ways to treat depression, schizophrenia, attention-deficit ... decreased motivation, Vanderbilt University researchers said. The researchers ...
Cached Medicine News:Health News:Less Invasive Heart Valve Replacement Works for Elderly: Study 2Health News:Less Invasive Heart Valve Replacement Works for Elderly: Study 3Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 2Health News:Once-Banned Bird Flu Study Suggests Pandemic Threat Is Real 3Health News:Combination of 2 drugs reverses liver tumors 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2
... Dolphin Medicals ONE™ technology is ... that uses a patented digital ... use an analog sensor. Dolphin ... digitize the signal in the ...
... Scientific Resolve Immersion Oil is a ... transmission throughout most of the UV-VIS ... low and high viscosity, is non-drying ... index of 1.5150. Resolve contains no ...
Immersion oil composed on polyester polyol, diphenyl cresyl phosphate and tricyclodecane dimethanol....
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Medicine Products: